Apellis Pharmaceuticals, Inc. (APLS)

19.94 -0.59 (-2.87%) USD  |  NASDAQ  |  Jan 16, 16:00
20.05 +0.11 (+0.55%) After-Hours: 20:00
More

Apellis Pharmaceuticals Proceeds from Stock Option Exercised (Quarterly)

Proceeds from Stock Option Exercised (Quarterly) Chart

View Proceeds from Stock Option Exercised (Quarterly) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Proceeds from Stock Option Exercised (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years

View Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Proceeds from Stock Option Exercised (Quarterly) Benchmarks

View Proceeds from Stock Option Exercised (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade